Although things look good for the next 2-3 months for the steel industry, the scenario for next year is not that bullish, said Rakesh Arora, Managing Partner, Go India Advisors.
For FY18 the total utilisation would be around 70 percent and in FY19 it would be closer to 100 percent, said Naresh Jalan, MD, Ramkrishna Forgings.
Margins for the company should also be headed towards 18-19 percent in FY18, said Sandeep Jain, Executive Director, Monte Carlo Fashions.
All insurance companies will eventually adjust to any change in the tax structure, said Arijit Basu, MD & CEO of SBI Life Insurance.
Talks of an increase in tax rate to corporate tax rate still premature, said Rajesh Sud, MD & CEO, Max Life Insurance.
JC Sharma, Vice Chairman said H2FY18 would be better for them than H1FY18 because post RERA and GST implementation, market understands which developers have the ability to deliver.
Expect consumption to move up faster in the next 30-60 days, said Sunil Kataria, Biz Head - India and SAARC, Godrej Consumer Products.
We must have the patience and the commitment to sustainability to make the IBC process work, said Uday Kotak, Exec VC & MD, Kotak Mahindra Bank.
By November-end the factual production will behind by around 60 million kilograms and that is quite a bit. So prices will go up and more so, for quality tea, said DP Maheshwari, MD & CEO, Jayshree tea
People have applied from 15 different states for this initial public offering (IPO). Company has become four times bigger in the five years, said Navin Korpe, CMD of ANI Integrated.
The total initial cost for MTHL is around Rs 13000 crore and the completion cost of the project is Rs 17,800 crore, said Urvinder Pal Singh Madan, The Commissioner, MMRDA.
“The fund raising plan is going pretty well and we have had the board, as well the shareholders' approval in place," Rajesh Jain, Joint MD at Panacea Biotec said.
The company has been told that the May inspection has been closed and they can carry on CAPA implementation, said Kiran Mazumdar Shaw, CMD, Biocon.
Amit Bakshi, MD, Eris Lifesciences said the brands that will be acquired are more of a franchise, which could be help built more number of brands and a bigger franchise could be created.
The focus of the company is on B2C (business to company) business and the regulated markets, which is core to the company's future growth, said Shashank Sinha, MD, Strides Shasun.
For the next fiscal the aim is to convert all into full-fledged banking branches that serve both asset and liability side, Sudha Suresh, MD & CEO, Ujjivan Financial Services.
It is far better to play the corporate facing private sector banks like Axis and ICICI Bank than PSU banks, said Suresh Ganapathy, Banking Analyst, Macquarie Capital Securities.
Demand for new vehicles in Q3 so far has been subdued but that for used commercial vehicles is good, said Umesh Revankar, MD, Shriram Transport Finance.
said Paul Hermelin, Chairman & Group CEO, Capgemini
Iron ore prices are more domestic-driven than international prices, said DS Ahluwalia, Director-Finance, NMDC.
With regards to recapitalization, the bank has worked out and submitted their requirement to the government both for the risk and growth capital, said Ashwani Kumar, Chairman & Managing Director of Dena Bank.
While selecting the companies for the ETF, they have been conscious about the valuations , said Nimesh Shah, MD & CEO, ICICI Prudential.
The proceeds from the sale of non-core assets will be used to pare debt, said Anil Sardana, MD & CEO, Tata Power.
The focus has been on profitable growth and the first half of FY18 has seen good earnings growth, said Sundeep Sikka, ED & CEO, Reliance Nippon Life AMC.
We are not shutting out anything organic and will continue to explore various alternatives, said Rajiv Lall, MD & CEO, IDFC Bank.